Bellevue Life Sciences-WRNTOSRHWPreferred / convertible
13F holders, Q1 2026 (March 31)16holders −1
0new positions
1sold out
1famous investor
$0.07avg. 13F price*
At the end of Q1 2026, 16 institutions reported holding Bellevue Life Sciences-WRNT (OSRHW) in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($57K), Toronto Dominion Bank ($34K) and Polar Asset Management Partners Inc. ($21K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Bellevue Life Sciences-WRNT
- Filed as
- OSR HLDGS INC (Q1 2026)
- CUSIP
- 68840D110
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
All 13F filers, Q4 2025 → Q1 2026: 122,675 shares bought and 246,000 shares sold, net −123,325 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Boothbay Fund Management, LLC | — | Reduce -69.4% | 95,040 | $57K |
| Toronto Dominion Bank | — | Add +25.1% | 611,947 | $34K |
| Polar Asset Management Partners Inc. | — | No change | 360,000 | $21K |
| Periscope Capital Inc. | — | No change | 299,900 | $17K |
| Clear Street Group Inc. | — | No change | 292,083 | $16K |
| LMR Partners LLP | — | No change | 253,001 | $14K |
| Rivernorth Capital Management, LLC | — | No change | 250,000 | $14K |
| Saba Capital Management, L.P. | — | No change | 250,000 | $14K |
| D. E. Shaw & Co. | — | No change | 150,000 | $9K |
| Wolverine Asset Management LLC | — | No change | 111,585 | $6K |
| Centiva Capital, LP | — | No change | 100,000 | $6K |
| Aristeia Capital, L.L.C. | — | No change | 73,341 | $4K |
| Mint Tower Capital Management B.V. | — | No change | 75,000 | $4K |
| Gabelli Funds LLC | — | No change | 27,050 | $1K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | No change | 20,800 | $1K |
| Flow Traders U.S. LLC | — | No change | 23,730 | $1K |
"% of holder's portfolio" is OSRHW's weight in each manager's 13F, not the share of Bellevue Life Sciences-WRNT the manager owns.